The current vaccine schedule in the United States may not be optimal, the Food and Drug Administration’s...

SAN DIEGO – September 25, 2025 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration...

SAN DIEGO – September 25, 2025 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration...

TUESDAY, Sept. 30, 2025 -- The U.S. Food and Drug Administration has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the...

September 25, 2025 -- MEDRx announced that the U.S. Food and Drug Administration (FDA) has approved Bondlido, a lidocaine*1 patch MEDRx Group and D....

The U.S. Food and Drug Administration (FDA)...

Health and Human Services Secretary Robert F. Kennedy Jr. told red-state governors the Food and Drug Administration is conducting a safety review of...

Health and Human Services Secretary Robert F. Kennedy Jr. told red-state governors the Food and Drug Administration is conducting a safety review of...

THURSDAY, Oct. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque...

WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...